Selected research
Market Analysis & Forecast
Global Exosome Isolation and Extraction Services Market Analysis and Forecast 2026-2032
Market perspective
The global Exosome Isolation and Extraction Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Exosome Isolation and Extraction Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Exosome Isolation and Extraction Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Exosome Isolation and Extraction Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Exosome Isolation and Extraction Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Exosome Isolation and Extraction Services include Umibi, Cusabio, Amyjet, Omiget, Ribobio, Echo Biotech, System Biosciences, Cusabio and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Exosome Isolation and Extraction Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Exosome Isolation and Extraction Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Exosome Isolation and Extraction Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Exosome Isolation and Extraction Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exosome Isolation and Extraction Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Exosome Isolation and Extraction Services revenue, projected growth trends, production technology, application and end-user industry.
Exosome Isolation and Extraction Services Segment by Company
Umibi
Cusabio
Amyjet
Omiget
Ribobio
Echo Biotech
System Biosciences
Cusabio
Creative Biolabs
Norgen Biotek
Fujifilm Wako
EZBioscience
Thermo
EVerZom
Exosome Isolation and Extraction Services Segment by Type
Animal Exosomes
Plant Exosomes
Microbial Exosomes
Exosome Isolation and Extraction Services Segment by Application
Laboratory
University
Bio Industry
Medical Industry
Exosome Isolation and Extraction Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation and Extraction Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation and Extraction Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation and Extraction Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Exosome Isolation and Extraction Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Exosome Isolation and Extraction Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Isolation and Extraction Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Exosomes
- Plant Exosomes
- Microbial Exosomes
Applications
- Laboratory
- University
- Bio Industry
- Medical Industry
Companies covered
- Umibi
- Cusabio
- Amyjet
- Omiget
- Ribobio
- Echo Biotech
- System Biosciences
- Cusabio
- Creative Biolabs
- Norgen Biotek
- Fujifilm Wako
- EZBioscience
- Thermo
- EVerZom
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Exosome Isolation and Extraction Services Market by Type
- 1.2.1 Global Exosome Isolation and Extraction Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Animal Exosomes
- 1.2.3 Plant Exosomes
- 1.2.4 Microbial Exosomes
- 1.3 Exosome Isolation and Extraction Services Market by Application
- 1.3.1 Global Exosome Isolation and Extraction Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Laboratory
- 1.3.3 University
- 1.3.4 Bio Industry
- 1.3.5 Medical Industry
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Exosome Isolation and Extraction Services Market Dynamics
- 2.1 Exosome Isolation and Extraction Services Industry Trends
- 2.2 Exosome Isolation and Extraction Services Industry Drivers
- 2.3 Exosome Isolation and Extraction Services Industry Opportunities and Challenges
- 2.4 Exosome Isolation and Extraction Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Exosome Isolation and Extraction Services Market Perspective (2021-2032)
- 3.2 Global Exosome Isolation and Extraction Services Growth Trends by Region
- 3.2.1 Global Exosome Isolation and Extraction Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Exosome Isolation and Extraction Services Market Size by Region (2021-2026)
- 3.2.3 Global Exosome Isolation and Extraction Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Exosome Isolation and Extraction Services Revenue by Players
- 4.1.1 Global Exosome Isolation and Extraction Services Revenue by Players (2021-2026)
- 4.1.2 Global Exosome Isolation and Extraction Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Exosome Isolation and Extraction Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Exosome Isolation and Extraction Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Exosome Isolation and Extraction Services Key Players Headquarters & Area Served
- 4.4 Global Exosome Isolation and Extraction Services Players, Product Type & Application
- 4.5 Global Exosome Isolation and Extraction Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Exosome Isolation and Extraction Services Market CR5 and HHI
- 4.6.3 2025 Exosome Isolation and Extraction Services Tier 1, Tier 2, and Tier 3
5 Exosome Isolation and Extraction Services Market Size by Type
- 5.1 Global Exosome Isolation and Extraction Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 5.3 Global Exosome Isolation and Extraction Services Revenue Market Share by Type (2021-2032)
6 Exosome Isolation and Extraction Services Market Size by Application
- 6.1 Global Exosome Isolation and Extraction Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 6.3 Global Exosome Isolation and Extraction Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Umibi
- 7.1.1 Umibi Company Information
- 7.1.2 Umibi Business Overview
- 7.1.3 Umibi Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Umibi Exosome Isolation and Extraction Services Product Portfolio
- 7.1.5 Umibi Recent Developments
- 7.2 Cusabio
- 7.2.1 Cusabio Company Information
- 7.2.2 Cusabio Business Overview
- 7.2.3 Cusabio Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Cusabio Exosome Isolation and Extraction Services Product Portfolio
- 7.2.5 Cusabio Recent Developments
- 7.3 Amyjet
- 7.3.1 Amyjet Company Information
- 7.3.2 Amyjet Business Overview
- 7.3.3 Amyjet Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Amyjet Exosome Isolation and Extraction Services Product Portfolio
- 7.3.5 Amyjet Recent Developments
- 7.4 Omiget
- 7.4.1 Omiget Company Information
- 7.4.2 Omiget Business Overview
- 7.4.3 Omiget Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Omiget Exosome Isolation and Extraction Services Product Portfolio
- 7.4.5 Omiget Recent Developments
- 7.5 Ribobio
- 7.5.1 Ribobio Company Information
- 7.5.2 Ribobio Business Overview
- 7.5.3 Ribobio Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Ribobio Exosome Isolation and Extraction Services Product Portfolio
- 7.5.5 Ribobio Recent Developments
- 7.6 Echo Biotech
- 7.6.1 Echo Biotech Company Information
- 7.6.2 Echo Biotech Business Overview
- 7.6.3 Echo Biotech Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Echo Biotech Exosome Isolation and Extraction Services Product Portfolio
- 7.6.5 Echo Biotech Recent Developments
- 7.7 System Biosciences
- 7.7.1 System Biosciences Company Information
- 7.7.2 System Biosciences Business Overview
- 7.7.3 System Biosciences Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.7.4 System Biosciences Exosome Isolation and Extraction Services Product Portfolio
- 7.7.5 System Biosciences Recent Developments
- 7.8 Cusabio
- 7.8.1 Cusabio Company Information
- 7.8.2 Cusabio Business Overview
- 7.8.3 Cusabio Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Cusabio Exosome Isolation and Extraction Services Product Portfolio
- 7.8.5 Cusabio Recent Developments
- 7.9 Creative Biolabs
- 7.9.1 Creative Biolabs Company Information
- 7.9.2 Creative Biolabs Business Overview
- 7.9.3 Creative Biolabs Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Creative Biolabs Exosome Isolation and Extraction Services Product Portfolio
- 7.9.5 Creative Biolabs Recent Developments
- 7.10 Norgen Biotek
- 7.10.1 Norgen Biotek Company Information
- 7.10.2 Norgen Biotek Business Overview
- 7.10.3 Norgen Biotek Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Norgen Biotek Exosome Isolation and Extraction Services Product Portfolio
- 7.10.5 Norgen Biotek Recent Developments
- 7.11 Fujifilm Wako
- 7.11.1 Fujifilm Wako Company Information
- 7.11.2 Fujifilm Wako Business Overview
- 7.11.3 Fujifilm Wako Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Fujifilm Wako Exosome Isolation and Extraction Services Product Portfolio
- 7.11.5 Fujifilm Wako Recent Developments
- 7.12 EZBioscience
- 7.12.1 EZBioscience Company Information
- 7.12.2 EZBioscience Business Overview
- 7.12.3 EZBioscience Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.12.4 EZBioscience Exosome Isolation and Extraction Services Product Portfolio
- 7.12.5 EZBioscience Recent Developments
- 7.13 Thermo
- 7.13.1 Thermo Company Information
- 7.13.2 Thermo Business Overview
- 7.13.3 Thermo Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Thermo Exosome Isolation and Extraction Services Product Portfolio
- 7.13.5 Thermo Recent Developments
- 7.14 EVerZom
- 7.14.1 EVerZom Company Information
- 7.14.2 EVerZom Business Overview
- 7.14.3 EVerZom Exosome Isolation and Extraction Services Revenue and Gross Margin (2021-2026)
- 7.14.4 EVerZom Exosome Isolation and Extraction Services Product Portfolio
- 7.14.5 EVerZom Recent Developments
8 North America
- 8.1 North America Exosome Isolation and Extraction Services Revenue (2021-2032)
- 8.2 North America Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 8.2.1 North America Exosome Isolation and Extraction Services Revenue by Type (2021-2026)
- 8.2.2 North America Exosome Isolation and Extraction Services Revenue by Type (2027-2032)
- 8.3 North America Exosome Isolation and Extraction Services Revenue Share by Type (2021-2032)
- 8.4 North America Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 8.4.1 North America Exosome Isolation and Extraction Services Revenue by Application (2021-2026)
- 8.4.2 North America Exosome Isolation and Extraction Services Revenue by Application (2027-2032)
- 8.5 North America Exosome Isolation and Extraction Services Revenue Share by Application (2021-2032)
- 8.6 North America Exosome Isolation and Extraction Services Revenue by Country
- 8.6.1 North America Exosome Isolation and Extraction Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Exosome Isolation and Extraction Services Revenue by Country (2021-2026)
- 8.6.3 North America Exosome Isolation and Extraction Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Exosome Isolation and Extraction Services Revenue (2021-2032)
- 9.2 Europe Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 9.2.1 Europe Exosome Isolation and Extraction Services Revenue by Type (2021-2026)
- 9.2.2 Europe Exosome Isolation and Extraction Services Revenue by Type (2027-2032)
- 9.3 Europe Exosome Isolation and Extraction Services Revenue Share by Type (2021-2032)
- 9.4 Europe Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 9.4.1 Europe Exosome Isolation and Extraction Services Revenue by Application (2021-2026)
- 9.4.2 Europe Exosome Isolation and Extraction Services Revenue by Application (2027-2032)
- 9.5 Europe Exosome Isolation and Extraction Services Revenue Share by Application (2021-2032)
- 9.6 Europe Exosome Isolation and Extraction Services Revenue by Country
- 9.6.1 Europe Exosome Isolation and Extraction Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Exosome Isolation and Extraction Services Revenue by Country (2021-2026)
- 9.6.3 Europe Exosome Isolation and Extraction Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Exosome Isolation and Extraction Services Revenue (2021-2032)
- 10.2 China Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 10.2.1 China Exosome Isolation and Extraction Services Revenue by Type (2021-2026)
- 10.2.2 China Exosome Isolation and Extraction Services Revenue by Type (2027-2032)
- 10.3 China Exosome Isolation and Extraction Services Revenue Share by Type (2021-2032)
- 10.4 China Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 10.4.1 China Exosome Isolation and Extraction Services Revenue by Application (2021-2026)
- 10.4.2 China Exosome Isolation and Extraction Services Revenue by Application (2027-2032)
- 10.5 China Exosome Isolation and Extraction Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Exosome Isolation and Extraction Services Revenue (2021-2032)
- 11.2 Asia Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 11.2.1 Asia Exosome Isolation and Extraction Services Revenue by Type (2021-2026)
- 11.2.2 Asia Exosome Isolation and Extraction Services Revenue by Type (2027-2032)
- 11.3 Asia Exosome Isolation and Extraction Services Revenue Share by Type (2021-2032)
- 11.4 Asia Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 11.4.1 Asia Exosome Isolation and Extraction Services Revenue by Application (2021-2026)
- 11.4.2 Asia Exosome Isolation and Extraction Services Revenue by Application (2027-2032)
- 11.5 Asia Exosome Isolation and Extraction Services Revenue Share by Application (2021-2032)
- 11.6 Asia Exosome Isolation and Extraction Services Revenue by Country
- 11.6.1 Asia Exosome Isolation and Extraction Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Exosome Isolation and Extraction Services Revenue by Country (2021-2026)
- 11.6.3 Asia Exosome Isolation and Extraction Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Exosome Isolation and Extraction Services Revenue (2021-2032)
- 12.2 SAMEA Exosome Isolation and Extraction Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Exosome Isolation and Extraction Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Exosome Isolation and Extraction Services Revenue by Type (2027-2032)
- 12.3 SAMEA Exosome Isolation and Extraction Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Exosome Isolation and Extraction Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Exosome Isolation and Extraction Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Exosome Isolation and Extraction Services Revenue by Application (2027-2032)
- 12.5 SAMEA Exosome Isolation and Extraction Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Exosome Isolation and Extraction Services Revenue by Country
- 12.6.1 SAMEA Exosome Isolation and Extraction Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Exosome Isolation and Extraction Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Exosome Isolation and Extraction Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst